Riyadh, Saudi Arabia

Hamad M Alkahtani

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.1

ph-index = 1


Company Filing History:


Years Active: 2018-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Hamad M Alkahtani

Introduction

Hamad M Alkahtani is a notable inventor based in Riyadh, Saudi Arabia. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds with potential applications in medicine. With a total of 2 patents, Alkahtani's work focuses on innovative methods for synthesizing compounds that may aid in cancer treatment.

Latest Patents

Alkahtani's latest patents include the development of 2-aminothiazoles derivatives and a method of preparation using super-paramagnetic iron oxide nanoparticles (SPIONs). This method involves mixing a diazonium salt with a reactant in the presence of a solvent, leading to the formation of a reaction intermediate. The subsequent mixing of this intermediate with hydrazine, facilitated by a SPIONs catalyst, results in the creation of a pyrazole compound. Additionally, he has worked on pyrido[2,3-d]pyrimidine derivatives as anticancer agents. These derivatives have shown promise in treating various cancers, including hepatic, colon, prostate, breast, and lung cancer.

Career Highlights

Throughout his career, Alkahtani has been associated with prominent institutions such as Imam Abdulrahman Bin Faisal University and King Saud University. His work in these universities has allowed him to contribute to research and development in the field of medicinal chemistry.

Collaborations

Alkahtani has collaborated with notable colleagues, including Samar A Abubshait and Haya A Abubshait. These collaborations have further enriched his research endeavors and have led to advancements in the field.

Conclusion

Hamad M Alkahtani's innovative work in the synthesis of chemical compounds highlights his significant contributions to medicinal chemistry. His patents reflect a commitment to developing solutions for critical health challenges, particularly in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…